{"transactions":[{"id":1217342,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-07T21:43:03.000Z","date":"2025-03-05","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":144497,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001649094-25-000045","document":"wk-form4_1741383777.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000045/wk-form4_1741383777.xml","form_type":"4"}},{"id":1217341,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-03-07T21:43:03.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":112,"price":72.37,"value":8105.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."}],"balance_after":41620,"source":{"system":"sec-edgar","filing":"0001649094-25-000045","document":"wk-form4_1741383777.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000045/wk-form4_1741383777.xml","form_type":"4"}},{"id":1217340,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-03-07T21:43:03.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":2267,"price":71.066,"value":161106.622,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $70.745 to $71.62. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":41732,"source":{"system":"sec-edgar","filing":"0001649094-25-000045","document":"wk-form4_1741383777.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000045/wk-form4_1741383777.xml","form_type":"4"}},{"id":1217339,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-03-07T21:43:03.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":2621,"price":70.388,"value":184486.948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $69.745 to $70.735. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":43999,"source":{"system":"sec-edgar","filing":"0001649094-25-000045","document":"wk-form4_1741383777.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000045/wk-form4_1741383777.xml","form_type":"4"}},{"id":1217338,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-03-07T21:43:03.000Z","date":"2025-03-05","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":21.41,"value":107050.0,"ownership":{"direct":true},"balance_after":46620,"source":{"system":"sec-edgar","filing":"0001649094-25-000045","document":"wk-form4_1741383777.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000045/wk-form4_1741383777.xml","form_type":"4"}},{"id":1235749,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T02:15:27.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":48357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of shares subject to the option vest on March 27, 2025, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":48357,"derivative":{"exercise_price":74.22,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":48357},"source":{"system":"sec-edgar","filing":"0001649094-25-000040","document":"wk-form4_1741054520.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000040/wk-form4_1741054520.xml","form_type":"4"}},{"id":1235748,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-03-04T02:15:27.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":616,"price":72.1,"value":44413.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":41620,"source":{"system":"sec-edgar","filing":"0001649094-25-000040","document":"wk-form4_1741054520.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000040/wk-form4_1741054520.xml","form_type":"4"}},{"id":1235747,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-03-04T02:15:27.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":470,"price":73.02,"value":34319.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":42236,"source":{"system":"sec-edgar","filing":"0001649094-25-000040","document":"wk-form4_1741054520.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000040/wk-form4_1741054520.xml","form_type":"4"}},{"id":1235746,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-03-04T02:15:27.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":14484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 7, 2025 and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":42706,"source":{"system":"sec-edgar","filing":"0001649094-25-000040","document":"wk-form4_1741054520.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000040/wk-form4_1741054520.xml","form_type":"4"}},{"id":1278719,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-07T21:04:12.000Z","date":"2025-02-05","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":149497,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001649094-25-000012","document":"wk-form4_1738962245.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000012/wk-form4_1738962245.xml","form_type":"4"}},{"id":1278718,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-02-07T21:04:12.000Z","date":"2025-02-05","kind":"sale","planned":true,"acquired":false,"shares":255,"price":91.708,"value":23385.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $91.69 to $91.71. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28222,"source":{"system":"sec-edgar","filing":"0001649094-25-000012","document":"wk-form4_1738962245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000012/wk-form4_1738962245.xml","form_type":"4"}},{"id":1278717,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-02-07T21:04:12.000Z","date":"2025-02-05","kind":"sale","planned":true,"acquired":false,"shares":1784,"price":91.052,"value":162436.768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $90.66 to $91.585. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28477,"source":{"system":"sec-edgar","filing":"0001649094-25-000012","document":"wk-form4_1738962245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000012/wk-form4_1738962245.xml","form_type":"4"}},{"id":1278716,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-02-07T21:04:12.000Z","date":"2025-02-05","kind":"sale","planned":true,"acquired":false,"shares":1755,"price":89.949,"value":157860.495,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $89.53 to $90.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":30261,"source":{"system":"sec-edgar","filing":"0001649094-25-000012","document":"wk-form4_1738962245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000012/wk-form4_1738962245.xml","form_type":"4"}},{"id":1278715,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-02-07T21:04:12.000Z","date":"2025-02-05","kind":"sale","planned":true,"acquired":false,"shares":635,"price":89.088,"value":56570.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $88.52 to $89.385. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":32016,"source":{"system":"sec-edgar","filing":"0001649094-25-000012","document":"wk-form4_1738962245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000012/wk-form4_1738962245.xml","form_type":"4"}},{"id":1278714,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-02-07T21:04:12.000Z","date":"2025-02-05","kind":"sale","planned":true,"acquired":false,"shares":571,"price":87.767,"value":50114.957,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $87.405 to $88.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":32651,"source":{"system":"sec-edgar","filing":"0001649094-25-000012","document":"wk-form4_1738962245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000012/wk-form4_1738962245.xml","form_type":"4"}},{"id":1278713,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-02-07T21:04:12.000Z","date":"2025-02-05","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":21.41,"value":107050.0,"ownership":{"direct":true},"balance_after":33222,"source":{"system":"sec-edgar","filing":"0001649094-25-000012","document":"wk-form4_1738962245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000012/wk-form4_1738962245.xml","form_type":"4"}},{"id":1308013,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T21:33:34.000Z","date":"2025-01-06","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":154497,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001649094-25-000004","document":"wk-form4_1736285608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000004/wk-form4_1736285608.xml","form_type":"4"}},{"id":1308012,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-01-07T21:33:34.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":125,"price":86.52,"value":10815.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."}],"balance_after":28222,"source":{"system":"sec-edgar","filing":"0001649094-25-000004","document":"wk-form4_1736285608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000004/wk-form4_1736285608.xml","form_type":"4"}},{"id":1308011,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-01-07T21:33:34.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":3921,"price":85.732,"value":336155.172,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"shares","element":"transactionShares","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $85.235 to $86.23. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28347,"source":{"system":"sec-edgar","filing":"0001649094-25-000004","document":"wk-form4_1736285608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000004/wk-form4_1736285608.xml","form_type":"4"}},{"id":1308010,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-01-07T21:33:34.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":954,"price":84.856,"value":80952.624,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $84.23 to $85.17. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":32268,"source":{"system":"sec-edgar","filing":"0001649094-25-000004","document":"wk-form4_1736285608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000004/wk-form4_1736285608.xml","form_type":"4"}},{"id":1308009,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2025-01-07T21:33:34.000Z","date":"2025-01-06","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":21.41,"value":107050.0,"ownership":{"direct":true},"balance_after":33222,"source":{"system":"sec-edgar","filing":"0001649094-25-000004","document":"wk-form4_1736285608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000004/wk-form4_1736285608.xml","form_type":"4"}},{"id":1339011,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-09T23:28:05.000Z","date":"2024-12-05","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":159497,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001649094-24-000118","document":"wk-form4_1733786878.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000118/wk-form4_1733786878.xml","form_type":"4"}},{"id":1339010,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-12-09T23:28:05.000Z","date":"2024-12-09","kind":"tax_withholding","planned":true,"acquired":false,"shares":475,"price":92.06,"value":43728.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units."}],"balance_after":28222,"source":{"system":"sec-edgar","filing":"0001649094-24-000118","document":"wk-form4_1733786878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000118/wk-form4_1733786878.xml","form_type":"4"}},{"id":1339009,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-12-09T23:28:05.000Z","date":"2024-12-05","kind":"sale","planned":true,"acquired":false,"shares":388,"price":92.901,"value":36045.588,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $92.29 to $93.11. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28697,"source":{"system":"sec-edgar","filing":"0001649094-24-000118","document":"wk-form4_1733786878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000118/wk-form4_1733786878.xml","form_type":"4"}},{"id":1339008,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-12-09T23:28:05.000Z","date":"2024-12-05","kind":"sale","planned":true,"acquired":false,"shares":3177,"price":91.912,"value":292004.424,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $91.265 to $92.175. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":29085,"source":{"system":"sec-edgar","filing":"0001649094-24-000118","document":"wk-form4_1733786878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000118/wk-form4_1733786878.xml","form_type":"4"}},{"id":1339007,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-12-09T23:28:05.000Z","date":"2024-12-05","kind":"sale","planned":true,"acquired":false,"shares":1435,"price":90.163,"value":129383.905,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $89.655 to $90.645. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":32262,"source":{"system":"sec-edgar","filing":"0001649094-24-000118","document":"wk-form4_1733786878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000118/wk-form4_1733786878.xml","form_type":"4"}},{"id":1339006,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-12-09T23:28:05.000Z","date":"2024-12-05","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":21.41,"value":107050.0,"ownership":{"direct":true},"balance_after":33697,"source":{"system":"sec-edgar","filing":"0001649094-24-000118","document":"wk-form4_1733786878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000118/wk-form4_1733786878.xml","form_type":"4"}},{"id":1339005,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-12-09T23:28:05.000Z","date":"2024-12-05","kind":"gift","planned":true,"acquired":false,"shares":110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a bona fide gift of the Issuer's Common Stock to a non-profit educational institution."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 184 shares acquired on November 15, 2024 under the Issuer's Employee Stock Purchase Plan."}],"balance_after":28697,"source":{"system":"sec-edgar","filing":"0001649094-24-000118","document":"wk-form4_1733786878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000118/wk-form4_1733786878.xml","form_type":"4"}},{"id":1371364,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Performance Stock Option (right to buy)","published_at":"2024-11-09T01:50:17.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":26125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As part of a company-wide grant to all eligible employees of the Issuer, on November 7, 2024 (the \"Grant Date\"), the Reporting Person was granted a performance stock option to purchase 26,125\nshares of the Issuer's Common Stock at a per share exercise price of $102.70. The option is subject to (1) a service-based vesting condition (vesting as to one-third of the shares on each of the third, fourth\nand fifth anniversaries of the Grant Date) and (2) a performance-vesting condition (which generally requires that the trading price of the Issuer's Common Stock average, over a one-year period, is at least $154.05 (150% of the Grant Date closing price))."}],"balance_after":26125,"derivative":{"exercise_price":102.7,"expiration_date":"2034-11-06","underlying":"Common Stock","underlying_shares":26125},"source":{"system":"sec-edgar","filing":"0001649094-24-000108","document":"wk-form4_1731117010.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000108/wk-form4_1731117010.xml","form_type":"4"}},{"id":1374191,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-06T21:15:17.000Z","date":"2024-11-05","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":164497,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001649094-24-000099","document":"wk-form4_1730927624.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000099/wk-form4_1730927624.xml","form_type":"4"}},{"id":1374190,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-11-06T21:15:17.000Z","date":"2024-11-05","kind":"sale","planned":true,"acquired":false,"shares":1273,"price":107.496,"value":136842.408,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $107.39 to $107.745. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28623,"source":{"system":"sec-edgar","filing":"0001649094-24-000099","document":"wk-form4_1730927624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000099/wk-form4_1730927624.xml","form_type":"4"}},{"id":1374189,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-11-06T21:15:17.000Z","date":"2024-11-05","kind":"sale","planned":true,"acquired":false,"shares":1524,"price":106.816,"value":162787.584,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $106.38 to $107.28. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":29896,"source":{"system":"sec-edgar","filing":"0001649094-24-000099","document":"wk-form4_1730927624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000099/wk-form4_1730927624.xml","form_type":"4"}},{"id":1374188,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-11-06T21:15:17.000Z","date":"2024-11-05","kind":"sale","planned":true,"acquired":false,"shares":1415,"price":105.718,"value":149590.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $105.35 to $106.17. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":31420,"source":{"system":"sec-edgar","filing":"0001649094-24-000099","document":"wk-form4_1730927624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000099/wk-form4_1730927624.xml","form_type":"4"}},{"id":1374187,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-11-06T21:15:17.000Z","date":"2024-11-05","kind":"sale","planned":true,"acquired":false,"shares":788,"price":104.8,"value":82582.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $104.345 to $105.33. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":32835,"source":{"system":"sec-edgar","filing":"0001649094-24-000099","document":"wk-form4_1730927624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000099/wk-form4_1730927624.xml","form_type":"4"}},{"id":1374186,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-11-06T21:15:17.000Z","date":"2024-11-05","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":21.41,"value":107050.0,"ownership":{"direct":true},"balance_after":33623,"source":{"system":"sec-edgar","filing":"0001649094-24-000099","document":"wk-form4_1730927624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000099/wk-form4_1730927624.xml","form_type":"4"}},{"id":1389297,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-09T00:29:50.000Z","date":"2024-10-07","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":169497,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001649094-24-000079","document":"wk-form4_1728433783.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000079/wk-form4_1728433783.xml","form_type":"4"}},{"id":1389296,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-10-09T00:29:50.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":67,"price":111.68,"value":7482.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."}],"balance_after":28623,"source":{"system":"sec-edgar","filing":"0001649094-24-000079","document":"wk-form4_1728433783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000079/wk-form4_1728433783.xml","form_type":"4"}},{"id":1389295,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-10-09T00:29:50.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":314,"price":110.505,"value":34698.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $110.235 to $111.12. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28690,"source":{"system":"sec-edgar","filing":"0001649094-24-000079","document":"wk-form4_1728433783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000079/wk-form4_1728433783.xml","form_type":"4"}},{"id":1389294,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-10-09T00:29:50.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":3147,"price":109.547,"value":344744.409,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $109.18 to $110.15. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":29004,"source":{"system":"sec-edgar","filing":"0001649094-24-000079","document":"wk-form4_1728433783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000079/wk-form4_1728433783.xml","form_type":"4"}},{"id":1389293,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-10-09T00:29:50.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":996,"price":108.687,"value":108252.252,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $108.085 to $109.05. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":32151,"source":{"system":"sec-edgar","filing":"0001649094-24-000079","document":"wk-form4_1728433783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000079/wk-form4_1728433783.xml","form_type":"4"}},{"id":1389292,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-10-09T00:29:50.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":476,"price":107.51,"value":51174.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $107.08 to $107.77. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":33147,"source":{"system":"sec-edgar","filing":"0001649094-24-000079","document":"wk-form4_1728433783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000079/wk-form4_1728433783.xml","form_type":"4"}},{"id":1389291,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-10-09T00:29:50.000Z","date":"2024-10-07","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":21.41,"value":107050.0,"ownership":{"direct":true},"balance_after":33623,"source":{"system":"sec-edgar","filing":"0001649094-24-000079","document":"wk-form4_1728433783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000079/wk-form4_1728433783.xml","form_type":"4"}},{"id":1391936,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-03T20:15:39.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":174497,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001649094-24-000075","document":"wk-form4_1727986533.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000075/wk-form4_1727986533.xml","form_type":"4"}},{"id":1391935,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-10-03T20:15:39.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":1030,"price":115.012,"value":118462.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $114.95 to $115.16. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28623,"source":{"system":"sec-edgar","filing":"0001649094-24-000075","document":"wk-form4_1727986533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000075/wk-form4_1727986533.xml","form_type":"4"}},{"id":1391934,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-10-03T20:15:39.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":3056,"price":114.369,"value":349511.664,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $113.83 to $114.82. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":29653,"source":{"system":"sec-edgar","filing":"0001649094-24-000075","document":"wk-form4_1727986533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000075/wk-form4_1727986533.xml","form_type":"4"}},{"id":1391933,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-10-03T20:15:39.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":1414,"price":113.381,"value":160320.734,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $112.795 to $113.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":32709,"source":{"system":"sec-edgar","filing":"0001649094-24-000075","document":"wk-form4_1727986533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000075/wk-form4_1727986533.xml","form_type":"4"}},{"id":1391932,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-10-03T20:15:39.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":true,"shares":5500,"price":21.41,"value":117755.0,"ownership":{"direct":true},"balance_after":34123,"source":{"system":"sec-edgar","filing":"0001649094-24-000075","document":"wk-form4_1727986533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000075/wk-form4_1727986533.xml","form_type":"4"}},{"id":1413909,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-05T21:13:55.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":179997,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001649094-24-000062","document":"wk-form4_1725570829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000062/wk-form4_1725570829.xml","form_type":"4"}},{"id":1413908,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-09-05T21:13:55.000Z","date":"2024-09-03","kind":"tax_withholding","planned":true,"acquired":false,"shares":2203,"price":110.15,"value":242660.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024 were sold by the Reporting Person."}],"balance_after":28623,"source":{"system":"sec-edgar","filing":"0001649094-24-000062","document":"wk-form4_1725570829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000062/wk-form4_1725570829.xml","form_type":"4"}},{"id":1413907,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-09-05T21:13:55.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":80,"price":117.28,"value":9382.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."}],"balance_after":30826,"source":{"system":"sec-edgar","filing":"0001649094-24-000062","document":"wk-form4_1725570829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000062/wk-form4_1725570829.xml","form_type":"4"}},{"id":1413906,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-09-05T21:13:55.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":144,"price":116.01,"value":16705.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."}],"balance_after":30906,"source":{"system":"sec-edgar","filing":"0001649094-24-000062","document":"wk-form4_1725570829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000062/wk-form4_1725570829.xml","form_type":"4"}},{"id":1413905,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-09-05T21:13:55.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":79,"price":114.96,"value":9081.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."}],"balance_after":31050,"source":{"system":"sec-edgar","filing":"0001649094-24-000062","document":"wk-form4_1725570829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000062/wk-form4_1725570829.xml","form_type":"4"}},{"id":1413904,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-09-05T21:13:55.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":122,"price":112.661,"value":13744.642,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $112.35 to $113.14. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":31129,"source":{"system":"sec-edgar","filing":"0001649094-24-000062","document":"wk-form4_1725570829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000062/wk-form4_1725570829.xml","form_type":"4"}},{"id":1413903,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-09-05T21:13:55.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":715,"price":111.566,"value":79769.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $111.16 to $112.14. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":31251,"source":{"system":"sec-edgar","filing":"0001649094-24-000062","document":"wk-form4_1725570829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000062/wk-form4_1725570829.xml","form_type":"4"}},{"id":1413902,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-09-05T21:13:55.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":523,"price":110.449,"value":57764.827,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $110.12 to $110.76. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":31966,"source":{"system":"sec-edgar","filing":"0001649094-24-000062","document":"wk-form4_1725570829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000062/wk-form4_1725570829.xml","form_type":"4"}},{"id":1413901,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-09-05T21:13:55.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":4,"price":107.67,"value":430.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."}],"balance_after":32489,"source":{"system":"sec-edgar","filing":"0001649094-24-000062","document":"wk-form4_1725570829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000062/wk-form4_1725570829.xml","form_type":"4"}},{"id":1413900,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-09-05T21:13:55.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":true,"shares":1667,"price":21.41,"value":35690.47,"ownership":{"direct":true},"balance_after":32493,"source":{"system":"sec-edgar","filing":"0001649094-24-000062","document":"wk-form4_1725570829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000062/wk-form4_1725570829.xml","form_type":"4"}},{"id":1440747,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (right to buy)","published_at":"2024-08-05T20:06:33.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":181664,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001649094-24-000042","document":"wk-form4_1722888387.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000042/wk-form4_1722888387.xml","form_type":"4"}},{"id":1440746,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-08-05T20:06:33.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":185,"price":79.2859,"value":14667.8915,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $79.23 to $79.34. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":30826,"source":{"system":"sec-edgar","filing":"0001649094-24-000042","document":"wk-form4_1722888387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000042/wk-form4_1722888387.xml","form_type":"4"}},{"id":1440745,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-08-05T20:06:33.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":1482,"price":78.7998,"value":116781.3036,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $78.23 to $79.22. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":31011,"source":{"system":"sec-edgar","filing":"0001649094-24-000042","document":"wk-form4_1722888387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000042/wk-form4_1722888387.xml","form_type":"4"}},{"id":1440744,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-08-05T20:06:33.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":true,"shares":1667,"price":21.41,"value":35690.47,"ownership":{"direct":true},"balance_after":32493,"source":{"system":"sec-edgar","filing":"0001649094-24-000042","document":"wk-form4_1722888387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000042/wk-form4_1722888387.xml","form_type":"4"}},{"id":1462954,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-02T20:17:50.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option shall vest on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":183331,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001649094-24-000028","document":"wk-form4_1719951462.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000028/wk-form4_1719951462.xml","form_type":"4"}},{"id":1462953,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-07-02T20:17:50.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":754,"price":76.8998,"value":57982.4492,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $76.58 to $77.085. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":30826,"source":{"system":"sec-edgar","filing":"0001649094-24-000028","document":"wk-form4_1719951462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000028/wk-form4_1719951462.xml","form_type":"4"}},{"id":1462952,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-07-02T20:17:50.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":913,"price":75.9272,"value":69321.5336,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $75.43 to $76.39. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":31580,"source":{"system":"sec-edgar","filing":"0001649094-24-000028","document":"wk-form4_1719951462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000028/wk-form4_1719951462.xml","form_type":"4"}},{"id":1462951,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-07-02T20:17:50.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":true,"shares":1667,"price":21.41,"value":35690.47,"ownership":{"direct":true},"balance_after":32493,"source":{"system":"sec-edgar","filing":"0001649094-24-000028","document":"wk-form4_1719951462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000028/wk-form4_1719951462.xml","form_type":"4"}},{"id":1484895,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-06-10T20:13:38.000Z","date":"2024-06-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":335,"price":70.97,"value":23774.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units."}],"balance_after":30826,"source":{"system":"sec-edgar","filing":"0001649094-24-000016","document":"wk-form4_1718050409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000016/wk-form4_1718050409.xml","form_type":"4"}},{"id":1489999,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-05T20:58:47.000Z","date":"2024-06-03","kind":"exercise","planned":true,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":184998,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001415889-24-015589","document":"form4-06052024_080641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924015589/form4-06052024_080641.xml","form_type":"4"}},{"id":1489998,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-06-05T20:58:47.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":260,"price":73.637,"value":19145.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $73.46 to $73.82. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":31161,"source":{"system":"sec-edgar","filing":"0001415889-24-015589","document":"form4-06052024_080641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924015589/form4-06052024_080641.xml","form_type":"4"}},{"id":1489997,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-06-05T20:58:47.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":656,"price":72.366,"value":47472.096,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $72.08 to $72.67. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":31421,"source":{"system":"sec-edgar","filing":"0001415889-24-015589","document":"form4-06052024_080641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924015589/form4-06052024_080641.xml","form_type":"4"}},{"id":1489996,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-06-05T20:58:47.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":751,"price":71.251,"value":53509.501,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $70.98 to $71.62. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":32077,"source":{"system":"sec-edgar","filing":"0001415889-24-015589","document":"form4-06052024_080641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924015589/form4-06052024_080641.xml","form_type":"4"}},{"id":1489995,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-06-05T20:58:47.000Z","date":"2024-06-03","kind":"exercise","planned":true,"acquired":true,"shares":1667,"price":21.41,"value":35690.47,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 564 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2024."}],"balance_after":32828,"source":{"system":"sec-edgar","filing":"0001415889-24-015589","document":"form4-06052024_080641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924015589/form4-06052024_080641.xml","form_type":"4"}},{"id":1528193,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (right to buy)","published_at":"2024-05-03T20:20:56.000Z","date":"2024-05-01","kind":"exercise","planned":true,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the shares subject to the option shall vest on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":186665,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001415889-24-012169","document":"form4-05032024_080526.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924012169/form4-05032024_080526.xml","form_type":"4"}},{"id":1528192,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-05-03T20:20:56.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":144,"price":63.903,"value":9202.032,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $63.87 to $63.905. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":30597,"source":{"system":"sec-edgar","filing":"0001415889-24-012169","document":"form4-05032024_080526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924012169/form4-05032024_080526.xml","form_type":"4"}},{"id":1528191,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-05-03T20:20:56.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":559,"price":61.948,"value":34628.932,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $61.755 to $62.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":30741,"source":{"system":"sec-edgar","filing":"0001415889-24-012169","document":"form4-05032024_080526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924012169/form4-05032024_080526.xml","form_type":"4"}},{"id":1528190,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-05-03T20:20:56.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":964,"price":61.297,"value":59090.308,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $60.76 to $61.69. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":31300,"source":{"system":"sec-edgar","filing":"0001415889-24-012169","document":"form4-05032024_080526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924012169/form4-05032024_080526.xml","form_type":"4"}},{"id":1528189,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-05-03T20:20:56.000Z","date":"2024-05-01","kind":"exercise","planned":true,"acquired":true,"shares":1667,"price":21.41,"value":35690.47,"ownership":{"direct":true},"balance_after":32264,"source":{"system":"sec-edgar","filing":"0001415889-24-012169","document":"form4-05032024_080526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924012169/form4-05032024_080526.xml","form_type":"4"}},{"id":1549594,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-03T20:22:48.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option shall vest on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":188332,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001415889-24-010001","document":"form4-04032024_080436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924010001/form4-04032024_080436.xml","form_type":"4"}},{"id":1549593,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-04-03T20:22:48.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":270,"price":67.416,"value":18202.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $67.37 to $68.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":30597,"source":{"system":"sec-edgar","filing":"0001415889-24-010001","document":"form4-04032024_080436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924010001/form4-04032024_080436.xml","form_type":"4"}},{"id":1549592,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-04-03T20:22:48.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":1397,"price":66.594,"value":93031.818,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $66.185 to $67.13. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":30867,"source":{"system":"sec-edgar","filing":"0001415889-24-010001","document":"form4-04032024_080436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924010001/form4-04032024_080436.xml","form_type":"4"}},{"id":1549591,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-04-03T20:22:48.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":true,"shares":1667,"price":21.41,"value":35690.47,"ownership":{"direct":true},"balance_after":32264,"source":{"system":"sec-edgar","filing":"0001415889-24-010001","document":"form4-04032024_080436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924010001/form4-04032024_080436.xml","form_type":"4"}},{"id":1603070,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-05T02:21:18.000Z","date":"2024-03-01","kind":"exercise","planned":true,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"1/4 of the shares subject to the option shall vest on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":189999,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001415889-24-006474","document":"form4-03052024_020312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006474/form4-03052024_020312.xml","form_type":"4"}},{"id":1603069,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-05T02:21:18.000Z","date":"2024-02-29","kind":"grant","planned":true,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/48 of shares subject to the option vest on March 31, 2024, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":50000,"derivative":{"exercise_price":73.82,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-006474","document":"form4-03052024_020312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006474/form4-03052024_020312.xml","form_type":"4"}},{"id":1603068,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-03-05T02:21:18.000Z","date":"2024-03-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":613,"price":71.55,"value":43860.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units."}],"balance_after":30597,"source":{"system":"sec-edgar","filing":"0001415889-24-006474","document":"form4-03052024_020312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006474/form4-03052024_020312.xml","form_type":"4"}},{"id":1603067,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-03-05T02:21:18.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":445,"price":74.771,"value":33273.095,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $74.55 to $74.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":31210,"source":{"system":"sec-edgar","filing":"0001415889-24-006474","document":"form4-03052024_020312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006474/form4-03052024_020312.xml","form_type":"4"}},{"id":1603066,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-03-05T02:21:18.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":703,"price":73.59,"value":51733.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $73.42 to $73.74. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":31655,"source":{"system":"sec-edgar","filing":"0001415889-24-006474","document":"form4-03052024_020312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006474/form4-03052024_020312.xml","form_type":"4"}},{"id":1603065,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-03-05T02:21:18.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":519,"price":73.025,"value":37899.975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $72.39 to $73.325. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":32358,"source":{"system":"sec-edgar","filing":"0001415889-24-006474","document":"form4-03052024_020312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006474/form4-03052024_020312.xml","form_type":"4"}},{"id":1603064,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-03-05T02:21:18.000Z","date":"2024-03-01","kind":"exercise","planned":true,"acquired":true,"shares":1667,"price":21.41,"value":35690.47,"ownership":{"direct":true},"balance_after":32877,"source":{"system":"sec-edgar","filing":"0001415889-24-006474","document":"form4-03052024_020312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006474/form4-03052024_020312.xml","form_type":"4"}},{"id":1603063,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-03-05T02:21:18.000Z","date":"2024-02-29","kind":"grant","planned":true,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on August 31, 2024 and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":31210,"source":{"system":"sec-edgar","filing":"0001415889-24-006474","document":"form4-03052024_020312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924006474/form4-03052024_020312.xml","form_type":"4"}},{"id":1658866,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-05T22:39:10.000Z","date":"2024-02-01","kind":"exercise","planned":true,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/4 of the shares subject to the option shall vest on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":191666,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001415889-24-002613","document":"form4-02052024_100258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924002613/form4-02052024_100258.xml","form_type":"4"}},{"id":1658865,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-02-05T22:39:10.000Z","date":"2024-02-01","kind":"sale","planned":true,"acquired":false,"shares":474,"price":75.391,"value":35735.334,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $75.01 to $75.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":20710,"source":{"system":"sec-edgar","filing":"0001415889-24-002613","document":"form4-02052024_100258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924002613/form4-02052024_100258.xml","form_type":"4"}},{"id":1658864,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-02-05T22:39:10.000Z","date":"2024-02-01","kind":"sale","planned":true,"acquired":false,"shares":343,"price":74.11,"value":25419.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $73.70 to $74.52. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":21184,"source":{"system":"sec-edgar","filing":"0001415889-24-002613","document":"form4-02052024_100258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924002613/form4-02052024_100258.xml","form_type":"4"}},{"id":1658863,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-02-05T22:39:10.000Z","date":"2024-02-01","kind":"sale","planned":true,"acquired":false,"shares":638,"price":73.165,"value":46679.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $72.695 to $73.67. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":21527,"source":{"system":"sec-edgar","filing":"0001415889-24-002613","document":"form4-02052024_100258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924002613/form4-02052024_100258.xml","form_type":"4"}},{"id":1658862,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-02-05T22:39:10.000Z","date":"2024-02-01","kind":"sale","planned":true,"acquired":false,"shares":212,"price":72.215,"value":15309.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $71.69 to $72.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":22165,"source":{"system":"sec-edgar","filing":"0001415889-24-002613","document":"form4-02052024_100258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924002613/form4-02052024_100258.xml","form_type":"4"}},{"id":1658861,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GEN COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2024-02-05T22:39:10.000Z","date":"2024-02-01","kind":"exercise","planned":true,"acquired":true,"shares":1667,"price":21.41,"value":35690.47,"ownership":{"direct":true},"balance_after":22377,"source":{"system":"sec-edgar","filing":"0001415889-24-002613","document":"form4-02052024_100258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924002613/form4-02052024_100258.xml","form_type":"4"}},{"id":1687776,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Corp Sec"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:26:08.000Z","date":"2024-01-02","kind":"exercise","planned":true,"acquired":true,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the shares subject to the option shall vest on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":193333,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001209191-24-000782","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919124000782/doc4.xml","form_type":"4"}},{"id":1687775,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2024-01-04T21:26:08.000Z","date":"2024-01-02","kind":"sale","planned":true,"acquired":false,"shares":928,"price":64.31,"value":59679.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $64.13 to $65.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":20710,"source":{"system":"sec-edgar","filing":"0001209191-24-000782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919124000782/doc4.xml","form_type":"4"}},{"id":1687774,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2024-01-04T21:26:08.000Z","date":"2024-01-02","kind":"sale","planned":true,"acquired":false,"shares":598,"price":63.593,"value":38028.614,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $63.13 to $64.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":21638,"source":{"system":"sec-edgar","filing":"0001209191-24-000782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919124000782/doc4.xml","form_type":"4"}},{"id":1687773,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2024-01-04T21:26:08.000Z","date":"2024-01-02","kind":"sale","planned":true,"acquired":false,"shares":141,"price":62.912,"value":8870.592,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $62.01 to $62.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":22236,"source":{"system":"sec-edgar","filing":"0001209191-24-000782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919124000782/doc4.xml","form_type":"4"}},{"id":1687772,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2024-01-04T21:26:08.000Z","date":"2024-01-02","kind":"exercise","planned":true,"acquired":true,"shares":1667,"price":21.41,"value":35690.47,"ownership":{"direct":true},"balance_after":22377,"source":{"system":"sec-edgar","filing":"0001209191-24-000782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919124000782/doc4.xml","form_type":"4"}},{"id":1716273,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82242,"kind":"person","name":"Eydelman Mikhail","position":1,"cik":"0001918033","reported_name":"Eydelman Mikhail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Gen Counsel & Corp Sec"}}],"security":"Stock Option (right to buy)","published_at":"2023-12-11T21:36:02.000Z","date":"2023-12-07","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option shall vest on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":195000,"derivative":{"exercise_price":21.41,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-058061","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123058061/doc4.xml","form_type":"4"}}],"next_cursor":"2023-12-11T21:36:02.000000Z,1716273"}